EDIT Earnings Forecast
Looking ahead, EDIT remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 8.45M and an EPS of -0.21.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Upward by 14.13% . These revisions correlate with a -49.26% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in EDIT long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
1Y
3Y
5Y
Currency: USD
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price0
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Unlock the reason behind revisions!
Revenue Estimates for Q4 2025
Revise Upward
+14.13%
In Past 3 Month
Stock Price
Go Down
-49.26%
In Past 3 Month
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Al Analysis
Earnings Surprise Analysis
Revenue
EPS
1Y
3Y
Al Analysis
Earnings Reaction
The chart below shows how EDIT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, EDIT sees a +10.66% change in stock price 10 days leading up to the earnings, and a -1.20% change 10 days following the report. On the earnings day itself, the stock moves by +5.30%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed 5.56% on the day following the earnings release and then changed by -0.79% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
Frequently Asked Questions
What were the key highlights of EDIT's latest earnings report for FY2025Q3?
EDIT reported its FY2025Q3 earnings on 2025-11-10, showcasing a revenue of 7.54M against an estimate of 4.94M, resulting in a 52.55% surprise. The EPS was 0, surpassing the expected -0.38 by 0% . The stock experienced a 2.02% price change on the earnings day and a 2.83% change over the next five days, reflecting market reactions to the results.
How did EDIT's stock price react after the FY2025Q3 earnings release?
Following EDIT's FY2025Q3 earnings announcement on 2025-11-10, the stock price moved by 2.02% on the day of the release. Over the subsequent five days, it saw a 2.83% change. Historically, EDIT's stock price tends to shift by an average of +10.66% in the 10 days leading up to earnings and -1.20% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for EDIT for 2025/Q4?
For 2025/Q4, analysts estimate EDIT’s annual revenue to reach 8.45M, while the EPS is projected at -0.21. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Revise Upward by 14.13% over the past three months, indicating analyst expectation in the company’s performance.
How does EDIT's stock price correlate with earnings forecast revisions?
The correlation between EDIT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Revise Upward by 14.13% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from EDIT's next earnings report?
Based on historical trends, EDIT's stock price typically moves by +10.66% in the 10 days before its earnings and -1.20% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.21 and revenue of 8.45M.
What is the sentiment in Editas Medicine, Inc. (EDIT) Q2 2024 Earnings Call Summary?
The earnings call summary and Q&A reveal mixed signals. While there are positive aspects like the collaboration with Bristol-Myers Squibb and ongoing development in the reni-cel program, there are concerns about declining revenue and increased R&D expenses. The management's vague responses on timelines and specifics add uncertainty. The strong cash position is a positive, but the market may react neutrally due to the lack of immediate catalysts and clear guidance. Without the market cap, a neutral rating is prudent.